Skip to main content

Advertisement

SpringerLink
Log in

Bone marrow sFRP5 level is negatively associated with bone formation markers

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Secreted frizzled-related protein 5 (sFRP5) level in bone marrow environment is inversely correlated with bone formation markers, suggesting that it decreases bone mass by inhibiting bone formation. Besides, it functions in a local fashion when regulating bone metabolism. sFRP5 may be a target when developing anti-osteoporotic agents.

Introduction

The purpose of the study is to investigate the relationship between bone marrow sFRP5 level and bone turnover state.

Methods

Eighty-three total knee arthroplasty patients were enrolled in this study. Data were collected prospectively and reviewed retrospectively. Lumbar spine and femoral neck bone mineral density (BMD), marrow adipose tissue (MAT) sFRP5 messenger RNA (mRNA) expression level, sFRP5 concentrations in marrow fluid and serum, concentrations of bone formation and resorption markers were measured for each participant.

Results

Marrow fluid sFRP5 concentration was positively correlated with both MAT sFRP5 expression (p = 0.040) and serum sFRP5 concentration (p = 0.043). Significantly positive correlation existed between MAT sFRP5 expression level and BMD (p < 0.05). Marrow fluid sFRP5 concentration had a moderate but not significant positive association with BMD. MAT sFRP5 was negatively related to serum bone formation markers including N-terminal propeptide of type 1 procollagen (P1NP) (p = 0.011), osteocalcin (OC), and alkaline phosphatase (ALP). Marrow fluid and serum sFRP5 concentrations also had mild negative correlations with bone formation markers but reached no significance. There was no significant correlation between bone resorption marker β-crosslaps (β-CTX) and sFRP5. The mRNA expression level of MAT sFRP5 was positively related with those of MAT leptin, peroxisome proliferator-activated receptor-γ (PPARγ), and adiponectin, and its correlation with leptin was statistically significant (p = 0.026).

Conclusions

Bone marrow sFRP5 level is closely correlated with BMD and bone formation markers. sFRP5 may be a potential negative regulator of bone mass by inhibiting bone formation. It may exert its effects on bone metabolism in a paracrine, rather than endocrine manner.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jönsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6:59–155

    Article  PubMed  Google Scholar 

  2. Greco EA, Lenzi A, Migliaccio S (2015) The obesity of bone. Ther Adv Endocrinol Metab 6:273–286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Muruganandan S, Sinal CJ (2014) The impact of bone marrow adipocytes on osteoblast and osteoclast differentiation. IUBMB Life 66:147–155

    Article  CAS  Google Scholar 

  4. Ouchi N, Higuchi A, Ohashi K, Oshima Y, Gokce N, Shibata R, Akasaki Y, Shimono A, Walsh K (2010) Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329:454–457

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Mori H, Prestwich TC, Reid MA, Longo KA, Gerin I, Cawthorn WP, Susulic VS, Krishnan V, Greenfield A, Macdougald OA (2012) Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Invest 122:2405–2416

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Deng D, Diao Z, Han X, Liu W (2016) Secreted frizzled-related protein 5 attenuates high phosphate-induced calcification in vascular smooth muscle cells by inhibiting the Wnt/ß-catenin pathway. Calcif Tissue Int 1:66–75

    Article  Google Scholar 

  7. Koza RA, Nikonova L, Hogan J, Rim JS, Mendoza T, Faulk C, Skaf J, Kozak LP (2006) Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet 2:769–780

    Article  CAS  Google Scholar 

  8. Mackay DL, Tesar PJ, Liang LN, Haynesworth SE (2006) Characterizing medullary and human mesenchymal stem cell-derived adipocytes. J Cell Physiol 207:722–728

    Article  CAS  PubMed  Google Scholar 

  9. Hardouin P, Rharass T, Lucas S (2016) Bone marrow adipose tissue: to be or not to be a typical adipose tissue? Front Endocrinol (Lausanne) 7:85

    Google Scholar 

  10. Zhang H, Xie H, Zhao Q, Xie GQ, Wu XP, Liao EY, Luo XH (2010) Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women. J Endocrinol Investig 33:707–711

    Article  CAS  Google Scholar 

  11. Liu LF, Shen WJ, Zhang ZH, Wang LJ, Kraemer FB (2010) Adipocytes decrease Runx2 expression in osteoblastic cells: roles of PPARγ and adiponectin. J Cell Physiol 225:837–845

    Article  CAS  PubMed  Google Scholar 

  12. Muruganandan S, Roman AA, Sinal CJ (2010) Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Miner Res 25:222–234

    Article  CAS  PubMed  Google Scholar 

  13. Wang R, Hong J, Liu R, Chen M, Xu M, Gu W, Zhang Y, Ma Q, Wang F, Shi J, Wang J, Wang W, Ning G (2014) SFRP5 acts as a mature adipocyte marker but not as a regulator in adipogenesis. J Mol Endocrinol 53:405–415

    Article  CAS  PubMed  Google Scholar 

  14. Canalis E (2013) Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches. Nat Rev Endocrinol 9:575–583

    Article  CAS  PubMed  Google Scholar 

  15. Carstensen M, Herder C, Kempf K, Erlund I, Martin S, Koenig W, Sundvall J, Bidel S, Kuha S, Roden M, Tuomilehto J (2013) Sfrp5 correlates with insulin resistance and oxidative stress. Eur J Clin Investig 43:350–357

    Article  CAS  Google Scholar 

  16. Hu W, Li L, Yang M, Luo X, Ran W, Liu D, Xiong Z, Liu H, Yang G (2013) Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. J Clin Endocrinol Metab 98:290–298

    Article  CAS  PubMed  Google Scholar 

  17. Hu Z, Deng H, Qu H (2013) Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes Res Clin Pract 99:391–395

    Article  CAS  PubMed  Google Scholar 

  18. Schulte DM, Müller N, Neumann K, Oberhäuser F, Faust M, Güdelhöfer H, Brandt B, Krone W, Laudes M (2012) Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. PLoS One 7:e32437

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Yue R, Zhou BO, Shimada IS, Zhao Z, Morrison SJ (2016) Leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow. Cell Stem Cell 18:782–796

    Article  CAS  PubMed  Google Scholar 

  20. Abbott MJ, Roth TM, Ho L, Wang L, O'Carroll D, Nissenson RA (2015) Negative skeletal effects of locally produced adiponectin. PLoS One 10:e0134290

    Article  PubMed  PubMed Central  Google Scholar 

  21. Yoshiko Y, Oizumi K, Hasegawa T, Minamizaki T, Tanne K, Maeda N, Aubin JE (2010) A subset of osteoblasts expressing high endogenous levels of PPARgamma switches fate to adipocytes in the rat calvaria cell culture model. PLoS One 5:e11782

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Rosen CJ, Klibanski A, Miller KK (2011) Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring) 19:49–53

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing, 400016, China

    H. Chen, Y. He, G. Dai, C. Zhao, W. Huang & D. Jiang

  2. Department of Rehabilitation, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

    D. Wu

Authors
  1. H. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. He
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Chen.

Ethics declarations

Ethics statement

This study was approved by the Institutional Review Board of the First Affiliated Hospital of Chongqing Medical University. Written informed consent was obtained from each participant.

Conflicts of interest

None.

Additional information

Hong Chen and Yao He contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, H., He, Y., Wu, D. et al. Bone marrow sFRP5 level is negatively associated with bone formation markers. Osteoporos Int 28, 1305–1311 (2017). https://doi.org/10.1007/s00198-016-3873-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-016-3873-3

Keywords

Search

Navigation